Jan. 17 at 11:10 PM
$ZYBT very quiet in here, live short interest 0.64%, CTB 34.45
OS: 47.39M
Float: 4.43M
Market Cap: ~
$55.4M
• IPO Equity
– Jan 2025 IPO: 1,500,000 shares @
$4.00 via F-1 (Kingswood), no warrants
No warrants, no convertibles, no equity lines, no SPAs, no variable-rate paper present. Cap table is clean post-IPO, but float is extremely thin relative to OS (4.43M vs 47.39M), implying tightly locked capital and potentially violent price discovery if volume chases.
ATM and Shelf
None disclosed.
Equity Lines
None disclosed.
Classic micro-float China biotech uplist with no dilution machinery visible. The real question is lock-up expirations and insider unlock cadence, not financings.
